Literature DB >> 2195344

The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China.

S C Lester1, M del Pilar Pla, F Wang, I Perez Schael, H Jiang, T F O'Brien.   

Abstract

BACKGROUND AND METHODS: The healthy members of a community represent its largest reservoir of bacteria resistant to antimicrobial agents. We compared the resistance to eight agents of Escherichia coli in stool samples from untreated, healthy children in cities on three continents.
RESULTS: When screened by a selective method that detected 1 resistant colony in 10,000 colonies, nearly half the children in Boston (18 of 39) had no resistant colonies--a finding consistent with the findings of other surveys performed in developed countries. However, all but 1 of 41 children screened in Caracas, Venezuela, and all but 2 of 53 in Qin Pu, China, carried resistant strains. Only 1 child in Boston but 25 in Caracas and 34 in Qin Pu carried strains resistant to trimethoprim. None of the children in Boston or Caracas but 17 in Qin Pu carried strains resistant to gentamicin. Among 10 colonies selected randomly from each stool sample, the average frequency of resistance in Caracas was 3.6 times greater than in Boston, and that in Qin Pu was 5.3 times greater. There was resistance to five or more antimicrobial agents in 20 percent of the Qin Pu strains and in 6 percent of the Caracas strains but in none of the Boston strains.
CONCLUSIONS: In addition to clinical isolates, as reported previously, the bacteria that colonize health children in the community may be resistant far more often in some regions than in others. A low rate of carriage of antimicrobial resistance in the community should become a public health goal.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2195344     DOI: 10.1056/NEJM199008023230501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  44 in total

Review 1.  Antibiotic use and emerging resistance: how can resource-limited countries turn the tide?

Authors:  Lisa M Bebell; Anthony N Muiru
Journal:  Glob Heart       Date:  2014-10-31

2.  Nosocomial spread of an amikacin resistance gene on both a mobilized, nonconjugative plasmid and a conjugative plasmid.

Authors:  J D Hopkins; A Flores; M del Pilar Pla; S Lester; T F O'Brien
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

Review 3.  Non-prescription antimicrobial use worldwide: a systematic review.

Authors:  Daniel J Morgan; Iruka N Okeke; Ramanan Laxminarayan; Eli N Perencevich; Scott Weisenberg
Journal:  Lancet Infect Dis       Date:  2011-06-12       Impact factor: 25.071

Review 4.  Mobile genetic elements of the human gastrointestinal tract: potential for spread of antibiotic resistance genes.

Authors:  Eileen Broaders; Cormac G M Gahan; Julian R Marchesi
Journal:  Gut Microbes       Date:  2013-04-12

5.  Risk factors for antibiotic-resistant Escherichia coli carriage in young children in Peru: community-based cross-sectional prevalence study.

Authors:  Henry D Kalter; Robert H Gilman; Lawrence H Moulton; Anna R Cullotta; Lilia Cabrera; Billie Velapatiño
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

Review 6.  Integrated Multilevel Surveillance of the World's Infecting Microbes and Their Resistance to Antimicrobial Agents.

Authors:  Thomas F O'Brien; John Stelling
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

7.  Emergence and dissemination of quinolone-resistant Escherichia coli in the community.

Authors:  J Garau; M Xercavins; M Rodríguez-Carballeira; J R Gómez-Vera; I Coll; D Vidal; T Llovet; A Ruíz-Bremón
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

Review 8.  Factors influencing the gut microbiome in children: from infancy to childhood.

Authors:  Shreyas V Kumbhare; Dhrati V V Patangia; Ravindra H Patil; Yogesh S Shouche; Nitinkumar P Patil
Journal:  J Biosci       Date:  2019-06       Impact factor: 1.826

9.  The prevalence of antibiotic-resistant faecal Escherichia coli in healthy volunteers in Venezuela.

Authors:  H J van de Mortel; E J Jansen; G J Dinant; N London; E Palacios Prü; E E Stobberingh
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

10.  Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam.

Authors:  M Kosseim; A Ronald; F A Plummer; L D'Costa; R C Brunham
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.